Newsummit Bio IPO Advisory

IPO Research - IPO Boutique



Home

Subscriptions



Company
Symbol
Price
Shares
Trade Date
Newsummit Biopharma HoldingsNSB
[ NYSE ]
0.00TBD
Underwriter(s):
Oppenheimer & Co., Cowen & Co.
Co-Manager(s):
Employees:
415
Founded:
 
Address:
2F, No. 780 Cailun Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai 201203, People's Republic of China
Phone:
86-21-5079-8788
Newsummit Bio Web Site:
http://www.newsummitbio.com


For IPO Boutique's "scale of 1 to 5" BUY rating on Newsummit Biopharma Holdings, and our comprehensive analysis, click the "Buy Market Research" link above.




About Newsummit Bio (adapted from Newsummit Bio prospectus):
Newsummit is a China-based new drug development process solutions provider. They offer a range of services for new drug development, aiming to provide clients with one-stop solutions for developing new drug candidates and making successful submissions for investigational new drug, or IND, and new drug application, or NDA, to the PRC State Food and Drug Administration, or the SFDA, in an efficient and cost-effective manner.

This description is adapted from Newsummit Bio prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus..


IPO Boutique aggregates information on public companies and private companies, such as Newsummit Bio "NSB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.




Need a recommendation?
Visit our Testimonials page and see over 200 investors singing our praises.



Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2014 IPO Boutique. All Rights Reserved